SHANGHAI HENLIUS BIOTECH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.5 HKD | +0.98% |
|
+11.34% | +18.71% |
| Apr. 26 | Shanghai Henlius Biotech's Cancer Drug Gets the Nod from US FDA | MT |
| Apr. 24 | Shanghai Henlius Biotech Doses 1st Patient in Fibrosis Drug Clinical Study in China | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 17.28 | 17.84 | 18.26 |
| Spread/Res. | -4.51% | -7.51% | -9.64% |
| Spread/Supp. | +9.27% | +21.15% | +28.50% |
| Support | 15.10 | 13.62 | 12.84 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- 2696 Stock
- Charts Shanghai Henlius Biotech, Inc.
